Latest Insider Transactions at Phreesia, Inc. (PHR)
This section provides a real-time view of insider transactions for Phreesia, Inc. (PHR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Phreesia, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Phreesia, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 18
2022
|
Michael J. Davidoff SVP, Payer Business |
SELL
Open market or private sale
|
Direct |
1,075
-1.0%
|
$26,875
$25.26 P/Share
|
|
Oct 14
2022
|
Evan Roberts Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,140
-0.3%
|
$47,080
$22.48 P/Share
|
|
Oct 14
2022
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
623
-0.67%
|
$13,706
$22.48 P/Share
|
|
Oct 14
2022
|
Randy Rasmussen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,219
-0.92%
|
$26,818
$22.48 P/Share
|
|
Oct 14
2022
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
1,749
-0.78%
|
$38,478
$22.48 P/Share
|
|
Oct 14
2022
|
Chaim Indig Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,660
-0.29%
|
$80,520
$22.48 P/Share
|
|
Oct 14
2022
|
Allison C Hoffman General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,128
-1.05%
|
$24,816
$22.48 P/Share
|
|
Oct 14
2022
|
Michael J. Davidoff SVP, Payer Business |
SELL
Payment of exercise price or tax liability
|
Direct |
1,123
-1.04%
|
$24,706
$22.48 P/Share
|
|
Sep 17
2022
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Indirect |
14
-0.25%
|
$378
$27.7 P/Share
|
|
Sep 16
2022
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Indirect |
35
-0.62%
|
$945
$27.7 P/Share
|
|
Sep 16
2022
|
Michael J. Davidoff SVP, Payer Business |
SELL
Open market or private sale
|
Direct |
1,296
-1.18%
|
$34,992
$27.6 P/Share
|
|
Sep 15
2022
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
1,290
-1.19%
|
$36,120
$28.58 P/Share
|
|
Sep 12
2022
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
822
-0.88%
|
$23,838
$29.19 P/Share
|
|
Sep 12
2022
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
1,854
+1.95%
|
-
|
|
Sep 12
2022
|
Evan Roberts Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,036
-0.28%
|
$59,044
$29.19 P/Share
|
|
Sep 12
2022
|
Evan Roberts Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,178
+0.44%
|
-
|
|
Sep 12
2022
|
Randy Rasmussen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,160
-0.87%
|
$33,640
$29.19 P/Share
|
|
Sep 12
2022
|
Randy Rasmussen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,178
+2.32%
|
-
|
|
Sep 12
2022
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
626
-0.28%
|
$18,154
$29.19 P/Share
|
|
Sep 12
2022
|
David Linetsky SVP, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
1,589
+0.7%
|
-
|
|
Sep 12
2022
|
Chaim Indig Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,496
-0.28%
|
$101,384
$29.19 P/Share
|
|
Sep 12
2022
|
Chaim Indig Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,457
+0.44%
|
-
|
|
Sep 12
2022
|
Allison C Hoffman General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,359
-1.24%
|
$39,411
$29.19 P/Share
|
|
Sep 12
2022
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
2,649
+2.35%
|
-
|
|
Sep 12
2022
|
Michael J. Davidoff SVP, Payer Business |
SELL
Payment of exercise price or tax liability
|
Direct |
1,353
-1.22%
|
$39,237
$29.19 P/Share
|
|
Sep 12
2022
|
Michael J. Davidoff SVP, Payer Business |
BUY
Grant, award, or other acquisition
|
Direct |
2,649
+2.33%
|
-
|
|
Aug 24
2022
|
Allison C Hoffman General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,916
-6.06%
|
$159,068
$23.85 P/Share
|
|
Jul 29
2022
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
372
+1.67%
|
$8,556
$23.49 P/Share
|
|
Jul 29
2022
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
372
+1.61%
|
$8,556
$23.49 P/Share
|
|
Jul 29
2022
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
372
+0.99%
|
$8,556
$23.49 P/Share
|
|
Jul 21
2022
|
Michael J. Davidoff SVP, Payer Business |
SELL
Open market or private sale
|
Direct |
1,404
-1.28%
|
$35,100
$25.0 P/Share
|
|
Jul 14
2022
|
Randy Rasmussen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,219
-0.92%
|
$26,818
$22.35 P/Share
|
|
Jul 14
2022
|
Evan Roberts Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,140
-0.3%
|
$47,080
$22.35 P/Share
|
|
Jul 14
2022
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
624
-0.68%
|
$13,728
$22.35 P/Share
|
|
Jul 14
2022
|
David Linetsky SVP, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
1,315
-0.58%
|
$28,930
$22.35 P/Share
|
|
Jul 14
2022
|
Chaim Indig Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,660
-0.29%
|
$80,520
$22.35 P/Share
|
|
Jul 14
2022
|
Allison C Hoffman General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,128
-0.98%
|
$24,816
$22.35 P/Share
|
|
Jul 14
2022
|
Michael J. Davidoff SVP, Payer Business |
SELL
Payment of exercise price or tax liability
|
Direct |
793
-0.72%
|
$17,446
$22.35 P/Share
|
|
Jul 11
2022
|
Gillian Munson Director |
SELL
Open market or private sale
|
Direct |
2,605
-5.54%
|
$65,125
$25.57 P/Share
|
|
Jul 07
2022
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+17.86%
|
$0
$0.84 P/Share
|
|
Jun 30
2022
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,397
+16.74%
|
-
|
|
Jun 30
2022
|
Randy Rasmussen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
581
+0.44%
|
$12,201
$21.26 P/Share
|
|
Jun 30
2022
|
Ramin Sayar Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,397
+37.76%
|
-
|
|
Jun 30
2022
|
Mark Douglas Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,397
+31.46%
|
-
|
|
Jun 30
2022
|
Michael Weintraub Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,397
+4.07%
|
-
|
|
Jun 30
2022
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,397
+23.44%
|
-
|
|
Jun 30
2022
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
245
+0.21%
|
$5,145
$21.26 P/Share
|
|
Jun 30
2022
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,397
+24.84%
|
-
|
|
Jun 24
2022
|
Michael J. Davidoff SVP, Payer Business |
SELL
Open market or private sale
|
Direct |
5,046
-4.37%
|
$126,150
$25.11 P/Share
|
|
May 16
2022
|
Gillian Munson Director |
SELL
Open market or private sale
|
Direct |
2,106
-11.16%
|
$33,696
$16.06 P/Share
|